Research
Cellular
GLP-1 receptor agonists safely cause weight loss and have potential weight-independent anti-inflammatory effects.
Practitioners may consider GLP-1 receptor agonists as a treatment option for weight loss and inflammation in these patient populations.
StrongSupportsmedium confidence
GLP-1 analogs safely cause weight loss and have potential weight-independent anti-inflammatory effects.
Why this rating
The claim is supported by a review of multiple studies.
Source
Glucagon-Like Peptide 1 Receptor Agonists in Patients With Inflammatory Arthritis or Psoriasis
Derin Karacabeyli et al. · JCR Journal of Clinical Rheumatology · 2023
review · n=19Cited 51×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →